GAXOS.AI INC
GXAINASDAQTrading Snapshot
- Day Range
- $0.44 β $0.54
- 52-Week Range
- $0.41 β $2.63
- Volume (shares)
- 200,875
- Avg Volume (shares)
- β
- Shares Outstanding
- 11.1M
- Next Earnings
- 2026-11-12
Fundamentals Snapshot
- Annual Revenue
- $2M
- Last Q Revenue
- $2M
- P/E Ratio
- -1.0
- P/S Ratio
- 0.9x
- EPS (TTM)
- $-0.37
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +2.5%
GAXOS.AI INC
GXAIAbout GAXOS.AI INC
Gaxos.ai Inc. specializes in the creation, acquisition, and ongoing management of digital games that incorporate non-fungible tokens (NFTs). The company also oversees a dedicated digital gaming platform that features its own proprietary titles, alongside games developed and published by external partners, all presented under the Gaxos brand. In January 2024, the organization transitioned from its previous identity, The NFT Gaming Company, Inc., to its current name, Gaxos.ai Inc. Established in 2021, the firm's operations are headquartered in Roseland, New Jersey.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates

Exagen (NASDAQ:XGN) versus Gaxos.ai (NASDAQ:GXAI) Financial Review
Exagen (NASDAQ: XGN - Get Free Report) and Gaxos.ai (NASDAQ: GXAI - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of

Gaxos.ai Inc. Raises $3.6 Million in Gross Proceeds from Warrant Exercise Transaction
Roseland, NJ, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQ: GXAI), (βGaxosβ or the βCompanyβ), a company developing artificial intelligence applications across various high-growth sectors, today announced the

Gaxos Announces Exercise of Warrants for Approximately $3.6 Million Gross Proceeds
Roseland, NJ, Aug. 14, 2026 (GLOBE NEWSWIRE) -- --Gaxos.ai Inc. (βGaxosβ or the βCompanyβ)(NASDAQ: GXAI), a company developing artificial intelligence applications across various high-growth sectors, today announced the

Gaxos Delivers Record Second-Quarter Revenue, Up 35.8% Sequentially and 1,337% Year over Year
Revenue growth significantly outpaces advertising expense growth as revenue generated per advertising dollar improves Roseland, NJ, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company")(NASDAQ: GXAI)

Comparing Gaxos.ai (NASDAQ:GXAI) and Castle Biosciences (NASDAQ:CSTL)
Castle Biosciences (NASDAQ: CSTL - Get Free Report) and Gaxos.ai (NASDAQ: GXAI - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the

Gaxos Announces $1,000,000 Share Repurchase Plan
Roseland, NJ , Aug. 03, 2026 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company")(NASDAQ: GXAI), a company developing artificial intelligence applications across various high-growth sectors, today announced that